Picture of Verve Therapeutics logo

VERV — Verve Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Brief: Eli Lilly Close To Buying Gene-Editing Biotech Verve Therapeutics - FT

June 16 (Reuters) -

ELI LILLY CLOSE TO BUYING GENE-EDITING BIOTECH VERVE THERAPEUTICS- FT

ELI LILLY IS IN ADVANCED TALKS TO BUY GENE EDITING START-UP VERVE THERAPEUTICS FOR UP TO $1.3BN - FT

Source text: https://on.ft.com/4e57goZ

Further company coverage: LLY.N

 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Verve Therapeutics

See all news